Directional Plk1 inhibition-driven cell cycle interruption using amphiphilic thin-coated peptide-lanthanide upconversion nanomaterials as in vivo tumor suppressors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Directional Plk1 inhibition-driven cell cycle interruption using amphiphilic thin-coated peptide-lanthanide upconversion nanomaterials as in vivo tumor suppressors

Published:2015 Issue:13 Volume:3 Page:2624-2634
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Chan Chi-Fai¹²³⁴,Lan Rongfeng¹²³⁴,Tsang Ming-Kiu⁵⁶⁴,Zhou Di⁷⁸⁹¹⁰¹¹,Lear Sam¹¹²¹³¹⁴,Chan Wai-Lun¹²³⁴,Cobb Steven L.¹¹²¹³¹⁴,Wong Wai-Kwok¹²³⁴,Hao Jianhua⁵⁶⁴,Wong Wing-Tak¹⁵⁶⁴¹⁶⁶,Wong Ka-Leung¹²³⁴¹⁷

Affiliation:

1. Department of Chemistry

2. Hong Kong Baptist University

3. Kowloon Tong

4. Hong Kong

5. Department of Applied Physics

6. The Hong Kong Polytechnic University

7. School of Chemistry and Material Engineering Jiangsu

8. Key Laboratory of Advanced Functional Materials

9. Changshu Institute of Technology

10. Changshu

11. China

12. Durham University

13. Durham

14. UK

15. Department of Applied Biological and Chemical Technology

16. State Key Laboratory for Chirosciences from The Ministry of Science and Technology of the People's Republic of China

17. Changshu Research Institute of Hong Kong Baptist University

Abstract

Polo-like kinase 1 (Plk1) is a major serine/threonine protein kinase which regulates key mitotic events.

Funder

Hong Kong Baptist University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2015/TB/C4TB02104E

Reference34 articles.

1. Polo-Like Kinase 1: Target and Regulator of Transcriptional Control

2. Getting in and out of mitosis with Polo-like kinase-1

3. Normal Cells, but Not Cancer Cells, Survive Severe Plk1 Depletion

4. Cancer Genome Landscapes

5. Shared and separate functions of polo-like kinases and aurora kinases in cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified synthetic peptides: from therapeutics to chemosensors;Sensors & Diagnostics;2024

2. Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer;Expert Opinion on Drug Discovery;2023-01-01

3. Construction of a phos-tag-directed self-assembled fluorescent magnetobiosensor for the simultaneous detection of multiple protein kinases;Journal of Materials Chemistry B;2022

4. Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1;JACS Au;2021-06-20

5. Recent progress in luminescent materials based on lanthanide complexes intercalated synthetic clays;Journal of Rare Earths;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3